Valuation : Shandong Linuo Pharmaceutical Packaging Co., Ltd.

Market Cap 9.76B 1.45B 1.25B 1.17B 1.07B 2.01B 138B 2.03B 13.91B 5.41B 70.06B 5.45B 5.33B 232B P/E 2026 *
96.5x
P/E 2027 * 73.8x
Enterprise Value 9.76B 1.45B 1.25B 1.17B 1.07B 2.01B 138B 2.03B 13.91B 5.41B 70.06B 5.45B 5.33B 232B EV / Sales 2026 *
8.96x
EV / Sales 2027 * 7.89x
Free-Float
67.87%
Yield 2026 *
-
Yield 2027 * -
08-24 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
06-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2025, Payable on 9 June 2026 CI
04-22 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-22 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announces Annual dividend, payable on June 09, 2026 CI
04-21 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announced that it expects to receive CNY 300 million in funding CI
04-07 Nuode Fund Management Co., Ltd., Caitong Fund Management Co., Ltd., Jinxiu Zhonghe Investment Management Co., Ltd. and Allianz Asset Management Co., Ltd acquired 2.99% stake in Shandong Linuo Pharmaceutical Packaging Co., Ltd. from Linuo Investment Holding Group Co., Ltd. for approximately CNY 130 million. CI
03-31 Shandong Linuo Pharmaceutical Packaging's controlling shareholder plans to sell 3.0% stake RE
12-15 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
12-15 Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback announced on February 7, 2025, has closed with 4,557,700 shares, representing 1.99% for CNY 81.11 million. CI
11-04 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Approves Board Elections CI
27/10/25 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
09/10/25 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
29/09/25 Shandong Linuo Pharmaceutical Packaging Co., Ltd. completed the acquisition of 30% stake in Suzhou Chuangyang New Materials Technology Co., Ltd. from Shanghai Miaoxiang Enterprise Management Consulting Co., Ltd., Taicang Chuangyang Qiyun Enterprise Management Partnership Enterprise (Limited Partnership), Shanghai Shizhi Enterprise Management Co., Ltd. and Shanghai Jiuban Intelligent Technology Co., Ltd. CI
1 day+1.73%
1 week-3.51%
Current month+13.38%
1 month+19.01%
3 months-10.96%
6 months+114.17%
Current year+113.81%
1 week 34.38
Extreme 34.38
38.5
1 month 32.4
Extreme 32.4
45.97
Current year 15.07
Extreme 15.07
76.3
1 year 15.07
Extreme 15.07
76.3
3 years 10.78
Extreme 10.78
76.3
5 years 10.78
Extreme 10.78
76.3
10 years 10.78
Extreme 10.78
76.3
Manager TitleAgeSince
Chief Executive Officer 46 15/04/2024
Director of Finance/CFO 45 29/11/2022
Investor Relations Contact - -
Director TitleAgeSince
Chairman 51 31/10/2025
Chairman 47 01/01/2024
Director/Board Member 54 06/04/2015
Change 5-day change 1-year change 3-year change Capi.($)
+1.73%-3.51%+97.02%+181.03% 1.45B
-0.56%-0.99%+2.72%+20.03% 3.68B
+0.15%+0.72%-18.47%-55.90% 2.83B
+0.05%+2.35%-13.84%-27.35% 1.89B
-1.62%+0.28%-44.03%-63.39% 1.12B
-0.14%-0.14%-15.09%-56.91% 710M
+4.42%+9.65%+46.46%+55.83% 685M
+0.09%-2.02%+41.03%+70.77% 623M
+3.60%+12.72%-12.40%-52.30% 528M
-1.27%-1.38%+92.73%+109.16% 359M
Average +0.64%+1.93%+17.61%+18.10% 1.39B
Weighted average by Cap. +0.26%+1.10%+6.95%+7.85%

Financials

2026 *2027 *
Net sales 1.09B 162M 140M 131M 120M 225M 15.42B 226M 1.55B 604M 7.82B 609M 595M 25.9B 1.24B 184M 159M 149M 136M 255M 17.52B 257M 1.76B 686M 8.88B 691M 676M 29.41B
Net income 103M 15.32M 13.19M 12.38M 11.3M 21.24M 1.46B 21.39M 147M 57.1M 739M 57.52M 56.27M 2.45B 137M 20.37M 17.54M 16.47M 15.04M 28.25M 1.94B 28.45M 195M 75.94M 983M 76.5M 74.84M 3.26B
Net Debt - -
Logo Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Shandong Linuo Pharmaceutical Packaging Co Ltd, formerly Shandong Linuo Technical Glass Co Ltd, is a China-based company specialized in the research, development, production and sales of borosilicate special glass. The Company's main products include medium borosilicate pharmaceutical glass and high borosilicate heat-resistant glass series products. Pharmaceutical glass products include low borosilicate pharmaceutical glass series and medium borosilicate pharmaceutical glass series, which are mainly used in medical packaging fields such as blood products, biopharmaceuticals, new drugs and special drugs, vaccines, etc. High borosilicate heat-resistant glass products include heat-resistant glassware, glass trays for microwave ovens, glass lenses, electric light source glass shells and electric light source glass tubes, and others, which are mainly used in residential life fields including dining utensils, kitchen utensils, lighting fixtures, and others.
Employees
1,403
Date Price Change Volume
31/08/26 CN¥37.63 +1.73% 9,901,579
28/08/26 CN¥36.99 -2.73% 10,916,002
27/08/26 CN¥38.03 +5.32% 14,560,991
26/08/26 CN¥36.11 -1.23% 11,987,161
25/08/26 CN¥36.56 -2.40% 15,799,051

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 301188 Stock